Viewing Study NCT05518318


Ignite Creation Date: 2025-12-25 @ 4:59 AM
Ignite Modification Date: 2025-12-26 @ 3:59 AM
Study NCT ID: NCT05518318
Status: UNKNOWN
Last Update Posted: 2022-08-26
First Post: 2022-08-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: GLS-010 Monotherapy Versus Chemotherapy in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma (R/R cHL)
Sponsor: Guangzhou Gloria Biosciences Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module